Digital therapeutics company, Mika Health, has recently announced a partnership with pharma giants AstraZeneca and Daiichi Sankyo to launch an initiative called “UNITE.” This initiative aims to provide digital therapeutic solutions to women undergoing breast cancer treatments. The Mika Health app offers cancer patients access to psychological support to help alleviate disease-related anxiety, depression, and stress. It allows patients to track medication side effects, receive reminders, access educational resources, receive nutrition advice, and manage appointments. The app has been certified as a medical device in the EU and can be personalized to cater to the specific type of cancer an individual has.
The partnership with AstraZeneca and Daiichi Sankyo will integrate Mika Health’s digital therapies with pharmaceutical therapies. Initially, German-speaking patients in Switzerland will have access to these offerings, with plans to expand to include French- and Italian-speaking regions in the future. Adam Nosal, head of oncology at AstraZeneca Switzerland, emphasized the increasing importance of digital therapies in modern cancer treatment. He believes that this collaboration with Mika Health will broaden access to holistic cancer care and provide valuable insights to enhance therapeutic options for cancer patients.
Mika Health has also joined forces with global nonprofit Cancer Support Community in a separate collaboration. This partnership offers an AI-enabled oncology-focused digital therapeutic free of charge for cancer patients and caregivers in the U.S. In addition, Mika Health partnered with AI oncology company Massive Bio through its platform. Patients using Mika’s digital therapies can take advantage of Massive Bio’s AI-enabled biomarker testing and clinical trial matching services.
The upcoming HIMSS AI in Healthcare Forum happening on September 5-6 in Boston provides further insights into the intersection of artificial intelligence and healthcare. Attendees can learn more about the latest developments in AI applications for improving patient outcomes in various healthcare settings.
In conclusion, digital health is becoming increasingly important for modern healthcare treatments as companies continue to develop new ways of integrating technology into patient care. With partnerships like UNITE and collaborations like those between Mika Health and Cancer Support Community or Massive Bio, we are seeing more innovative solutions being developed that aim
